These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23302165)

  • 1. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
    Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
    Liu Y; Cui Y; Yu L; Zhang P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
    Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
    Liu J; Lin G; Huang J; Jiang Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
    Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
    Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
    Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
    Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
    Chung JW; Yoon TH
    Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
    Ren X; Cui P; Chen W; Xu M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of nuclear factor-kappaB and aberrant gene expression of interleukin 6 in middle ear cholesteatoma].
    Xu Y; Tao ZZ; Hua QQ; Wang XC; Xiao BK; Chen SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):192-6. PubMed ID: 19558856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
    Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
    Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
    Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.